Related Experiment Video

Updated: Feb 8, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.5K

[Cardiomyopathies]

E Kuhn

    Fortschritte Der Medizin
    |April 6, 1978
    PubMed

    Insights

    Cardiomyopathy, a cardiac muscle dysfunction, is classified by genetic and morphological traits, including inherited and sporadic forms. Diagnosis, prognosis, and treatment of these heterogeneous heart muscle diseases are reviewed.

    Area of Science:

    • Cardiology
    • Genetics
    • Pathology

    Context:

    • Cardiomyopathy represents a group of cardiac muscle diseases with diverse etiologies.
    • Understanding the genetic basis is crucial for classifying and managing cardiomyopathies.
    • Heterogeneity within cardiomyopathy subtypes necessitates further research into structural and enzymatic markers.

    Purpose:

    • To define and classify cardiomyopathies based on genetic, morphological, and functional criteria.
    • To review diagnostic methods for cardiomyopathy.
    • To provide an overview of the prognosis and treatment strategies for various cardiomyopathies.

    Summary:

    • Cardiomyopathy is defined as cardiac muscle dysfunction of unknown origin.
    • Classification includes autosomal dominant inheritance with (obstructive/non-obstructive) or without asymmetric septal hypertrophy (ASH), autosomal recessive inheritance, and sporadic forms.
    • The study also evaluates diagnostic approaches and reviews prognosis and treatment.

    Impact:

    • Provides a structured classification framework for cardiomyopathies.
    • Highlights the need for further subdivision of heterogeneous cardiomyopathy groups.
    • Aids clinicians in understanding diagnostic, prognostic, and therapeutic aspects of cardiomyopathy.

    More Related Videos

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    5.4K
    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    14.0K

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    509
    Cardiomyopathy VI: Nursing Management01:29

    Cardiomyopathy VI: Nursing Management

    Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
    360
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    462
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    575
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    575
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    613